The pandemic continues to cause unprecedented disruption across industries worldwide.
Get detailed insights regarding the impact of COVID-19 on the market.
We expect the global intravenous solutions market to grow at a CAGR of 5.96% during 2022-2027.
The growing awareness towards the faster response time and higher efficacy of IV solution therapy represents one of the factors catalyzing the global intravenous solutions market.
Sudden outbreak of the COVID-19 pandemic has led to the increasing demand for intravenous solutions for health recovery of patients affected by the coronavirus to provide salt, sugar, and water directly into their venous circulation.
Based on the type, the global intravenous solutions market has been segmented into partial parenteral nutrition and total parenteral nutrition. Currently, total parental nutrition holds the majority of the total market share.
Based on the nutrients, the global intravenous solutions market can be divided into carbohydrates, salts and electrolytes, minerals, vitamins, and amino acids. Among these, salts and electrolytes exhibit a clear dominance in the market.
On a regional level, the market has been classified into North America, Asia Pacific, Europe, Latin America, and Middle East and Africa, where North America currently dominates the global market.
Some of the major players in the global intravenous solutions market include Ajinomoto, B. Braun Melsungen, Baxter International Inc., Grifols, and Otsuka Pharmaceutical.
Immunotherapy Drugs Market by Type (Monoclonal Antibodies, Vaccines, Interferons Alpha and Beta, Interleukins), Therapy Area (Cancer, Autoimmune and Inflammatory Diseases, Infectious Diseases, and Others), End User (Hospitals, Clinics, and Others), and Region 2023-2028
REACH OUT TO US
Call us on
( US: +1-631-791-1145 )
( UK: +44-753-713-2163 )
( India: +91 120 433 0800 )
Drop us an email at